NCT04003233 (UniPOWR) is a NA clinical trial of SDS in Early-Onset Scoliosis Deformity of Spine (Disorder), sponsored by UMC Utrecht.

Who is sponsoring NCT04003233?

NCT04003233 is sponsored by UMC Utrecht.

What drugs are being tested in NCT04003233?

Interventions in NCT04003233: SDS, MID-C.

Is NCT04003233 still recruiting?

NCT04003233 is currently withdrawn. Last updated 23 March 2020.

Last reviewed 2020-03-23 · How we verify

NCT04003233: UniPOWR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Limited-efficacy Testing of Spring Distraction System (SDS) and Unilateral One-way Rod (MID-C) for Early Onset Scoliosis

Withdrawn NA Last updated 23 March 2020

What this trial tests

NA trial testing SDS in Early-Onset Scoliosis Deformity of Spine (Disorder). Withdrawn.

Timeline

1 July 2019

Primary endpoint
1 July 2022

1 December 2022

Quick facts

Lead sponsor	UMC Utrecht
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 July 2019
Primary completion	1 July 2022
Estimated completion	1 December 2022
Sites	2 locations across Netherlands

Drugs / interventions tested

SDS
MID-C

Conditions studied

Early-Onset Scoliosis Deformity of Spine (Disorder) — all drugs for Early-Onset Scoliosis Deformity of Spine (Disorder) →
Idiopathic Scoliosis — all drugs for Idiopathic Scoliosis →

Sponsor

UMC Utrecht — full company profile →

Who can join

Adults 6 to 12, any sex, with Early-Onset Scoliosis Deformity of Spine (Disorder) or Idiopathic Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to investigate the limited efficacy of these innovative surgical solutions in treatment of Early Onset Scoliosis (EOS) in terms of maintaining reduction while maintaining spinal growth. The secondary aim is to compare both devices for these and other parameters as well as safety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of SDS

Trials testing the same drug.

NCT04021784 — Limited-efficacy Testing of SDS and NEMOST for Early Onset Neuromuscular Scoliosis · NA · completed

Other UMC Utrecht trials

Trials by the same sponsor.

NCT07512336 — A Randomized Intra-Patient Controlled Trial of MagnetOs™ Putty vs Autograft in Instrumented Posterolateral Spinal Fusion · NA · not yet recruiting
NCT07485985 — Coronary Sinus Reducer Therapy for Persisting Angina · NA · not yet recruiting
NCT07449052 — Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease · NA · not yet recruiting
NCT05375708 — Systemic Therapy in Combination with Stereotactic Radiotherapy in Patients with Metastatic Colorectal Cancer Up to 10 Me · Phase 2 · suspended
NCT06898541 — Coronary Sinus Reducer in Coronary Microvascular Disease · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04003233 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by UMC Utrecht
Last refreshed: 23 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04003233.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing